These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 33854108)
1. Prediction of single-cell mechanisms for disease progression in hypertrophic remodelling by a trans-omics approach. Hamano M; Nomura S; Iida M; Komuro I; Yamanishi Y Sci Rep; 2021 Apr; 11(1):8112. PubMed ID: 33854108 [TBL] [Abstract][Full Text] [Related]
2. Differential role of Nkx2-5 in activation of the atrial natriuretic factor gene in the developing versus failing heart. Warren SA; Terada R; Briggs LE; Cole-Jeffrey CT; Chien WM; Seki T; Weinberg EO; Yang TP; Chin MT; Bungert J; Kasahara H Mol Cell Biol; 2011 Nov; 31(22):4633-45. PubMed ID: 21930795 [TBL] [Abstract][Full Text] [Related]
3. Antisense regulation of atrial natriuretic peptide expression. Celik S; Sadegh MK; Morley M; Roselli C; Ellinor PT; Cappola T; Smith JG; Gidlöf O JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31503546 [TBL] [Abstract][Full Text] [Related]
4. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice. Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805 [TBL] [Abstract][Full Text] [Related]
6. Structure and function of the Nppa-Nppb cluster locus during heart development and disease. Man J; Barnett P; Christoffels VM Cell Mol Life Sci; 2018 Apr; 75(8):1435-1444. PubMed ID: 29302701 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467 [TBL] [Abstract][Full Text] [Related]
9. Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide. Mascareno E; Beckles D; Dhar-Mascareno M; Siddiqui MA Vascul Pharmacol; 2009; 51(2-3):198-204. PubMed ID: 19560554 [TBL] [Abstract][Full Text] [Related]
10. A transgenic mouse model for the simultaneous monitoring of ANF and BNP gene activity during heart development and disease. Sergeeva IA; Hooijkaas IB; Van Der Made I; Jong WM; Creemers EE; Christoffels VM Cardiovasc Res; 2014 Jan; 101(1):78-86. PubMed ID: 24104878 [TBL] [Abstract][Full Text] [Related]
11. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy. Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324 [TBL] [Abstract][Full Text] [Related]
12. The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling. Melleby AO; Strand ME; Romaine A; Herum KM; Skrbic B; Dahl CP; Sjaastad I; Fiane AE; Filmus J; Christensen G; Lunde IG PLoS One; 2016; 11(10):e0165079. PubMed ID: 27768722 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation. Menon A; Hong L; Savio-Galimberti E; Sridhar A; Youn SW; Zhang M; Kor K; Blair M; Kupershmidt S; Darbar D J Mol Cell Cardiol; 2019 Jul; 132():24-35. PubMed ID: 31077706 [TBL] [Abstract][Full Text] [Related]
14. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p. Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004 [TBL] [Abstract][Full Text] [Related]
15. Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy. Ren Z; Yu P; Li D; Li Z; Liao Y; Wang Y; Zhou B; Wang L Circulation; 2020 May; 141(21):1704-1719. PubMed ID: 32098504 [TBL] [Abstract][Full Text] [Related]
16. High-throughput single-molecule RNA imaging analysis reveals heterogeneous responses of cardiomyocytes to hemodynamic overload. Satoh M; Nomura S; Harada M; Yamaguchi T; Ko T; Sumida T; Toko H; Naito AT; Takeda N; Tobita T; Fujita T; Ito M; Fujita K; Ishizuka M; Kariya T; Akazawa H; Kobayashi Y; Morita H; Takimoto E; Aburatani H; Komuro I J Mol Cell Cardiol; 2019 Mar; 128():77-89. PubMed ID: 30611794 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828 [TBL] [Abstract][Full Text] [Related]
18. Optimization and enrichment of induced cardiomyocytes derived from mouse fibroblasts by reprogramming with cardiac transcription factors. Tian J; Wang R; Hou Q; Li M; Chen L; Deng X; Zhu Z; Zhao Y; He W; Fu X Mol Med Rep; 2018 Mar; 17(3):3912-3920. PubMed ID: 29257325 [TBL] [Abstract][Full Text] [Related]
19. Distinct regulation of developmental and heart disease-induced atrial natriuretic factor expression by two separate distal sequences. Horsthuis T; Houweling AC; Habets PE; de Lange FJ; el Azzouzi H; Clout DE; Moorman AF; Christoffels VM Circ Res; 2008 Apr; 102(7):849-59. PubMed ID: 18276916 [TBL] [Abstract][Full Text] [Related]
20. A multi-omics approach to identify molecular alterations in a mouse model of heart failure. Zhou X; Zhang S; Zhao Y; Wang W; Zhang H Theranostics; 2022; 12(4):1607-1620. PubMed ID: 35198060 [No Abstract] [Full Text] [Related] [Next] [New Search]